Latest Breaking News On - Aldea pharmaceuticals - Page 1 : comparemela.com
Sagimet Biosciences (SGMT) Announces Leadership Changes, COO to Assume Position as CFO
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Sagimet Biosciences Announces Leadership Changes
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Cognoa Appoints Seasoned Financial Executive, Tony Rimac, as Chief Financial Officer
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Biosketch
Bill Yelle has over 30 years of experience in the biopharmaceutical industry, ranging from large pharma to early stage, venture-backed companies. He currently serves as an Entrepreneur in Residence at Partners Innovation Fund (PIF) as well as an Adjunct Faculty Member at The Manning School of Business at UMass Lowell.
Before joining PIF, Bill was Executive Chairman of Envisia Therapeutics, as well as an advisor to several entrepreneurial startups. Prior to Envisia, Bill served as CEO of Aldea Pharmaceuticals, where he successfully completed a Series B raise and brought two programs into the clinic. Prior to Aldea, he was Senior Vice President of Corporate Development and Licensing for Sunovion Pharmaceuticals Inc. (formerly Sepracor Inc.), where he was responsible for the consummation of over 30 material transactions, the most notable being the company’s sale to Dainippon Sumitomo Pharma for $2.6 billion in 2009.